IB2015055083 PROCESS FOR THE PREPARATION OF REGORAFENIB AND ITS CRYSTALLINE FORMS

1. (WO2016005874) PROCESS FOR THE PREPARATION OF REGORAFENIB AND ITS CRYSTALLINE FORMS

National Phase

↓

Latest bibliographic data on file with the International Bureau

Pub. No.:		WO/2016/005874		International Application No.:		PCT/IB2015/055083
Publication Date:		14.01.2016		International Filing Date:		06.07.2015

IPC:

C07D 213/81 (2006.01)

Applicants:

SHILPA MEDICARE LIMITED [IN/IN]; #12-6-214/A1,Hyderabad Road Raichur-584 135, Karnataka (IN)

Inventors:

RAMPALLI, Sriram; (IN).
UPALLA, Lav Kumar; (IN).
RAMACHANDRULA, Krishna Kumar; (IN).
PUROHIT, Prashant; (IN).
AKSHAY KANT, Chaturvedi; (IN)

Priority Data:

3391/CHE/2014		09.07.2014		IN
3396/CHE/2014		09.07.2014		IN

Title

(EN) PROCESS FOR THE PREPARATION OF REGORAFENIB AND ITS CRYSTALLINE FORMS
(FR) PROCÉDÉ POUR LA PRÉPARATION DU RÉGORAFÉNIB ET SES FORMES CRISTALLINES

Abstract:

(EN)The present invention relates to a process for the preparation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide or Regorafenib (I): Formula (I). The present invention further relates to a process for the purification of 4-[4-({[4-chloro-3-(trifluoromethyl) phenyl] carbamoyl} amino)-3-fluorophenoxy]-N-methylpyridine-2- carboxamide or Regorafenib (I) to provide highly pure material. The present invention further relates to a process for the preparation stable crystalline material of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]- N-methyl pyridine-2-carboxamide or Regorafenib (I) useful in the preparation of pharmaceutical compositions for the treatment of cancer.
(FR)La présente invention concerne un procédé pour la préparation de 4-[4-({[4-chloro-3- (trifluorométhyle)phényl]carbamoyl}amino)-3-fluorophénoxy]-N-méthylpyridine -2-carboxamide ou du régorafénib (I) : Formule (I). La présente invention concerne en outre un procédé pour la purification de 4-[4-({ [4-chloro-3-(trifluorométhyle)phényl]carbamoyl}amino)-3-fluorophénoxy]-N-méthylpyridine-2-carboxamide ou du régorafénib (I) pour fournir un matériau hautement pur. La présente invention concerne en outre un procédé pour la préparation d'un matériau cristallin stable de 4-[4-({[4-chloro-3-(trifluorométhyl)phényl]carbamoyl}amino) -3-fluorophénoxy]-N-méthylpyridine-2-carboxamide ou de régorafénib (I) utiles dans la préparation de compositions pharmaceutiques pour le traitement du cancer.

Designated States:

AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).

Publication Language:	English (EN)
Filing Language:	English (EN)

Default Search Form
Default Tab Search Form
Interface Language
Skins
Multiple Windows Interface
Tooltip Help
IPC Tooltip Help